Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bipolar Enbloc Versus Thulium-Yag Enbloc Resection Of Bladder Tumors: A Randomized Controlled Trial

NCT06119724 is registered in ClinicalTrials.gov with Menoufia University as lead sponsor.

NCT NCT06119724
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06119724 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bipolar Enbloc Versus Thulium-Yag Enbloc Resection Of Bladder Tumors: A Randomized Controlled Trial
Lead sponsor
Menoufia University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
June 11, 2023
Completion date
December 29, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer